0001209191-11-052256.txt : 20111020 0001209191-11-052256.hdr.sgml : 20111020 20111020113647 ACCESSION NUMBER: 0001209191-11-052256 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111019 FILED AS OF DATE: 20111020 DATE AS OF CHANGE: 20111020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rubin Marc CENTRAL INDEX KEY: 0001412377 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31791 FILM NUMBER: 111149574 MAIL ADDRESS: STREET 1: C/O TITAN PHARMACEUTICALS, INC. STREET 2: 400 OYSTER POINT BLVD., STE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC CENTRAL INDEX KEY: 0001133416 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043562325 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7 WELLS AVENUE STREET 2: STE 34 CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-559-0033 MAIL ADDRESS: STREET 1: 7 WELLS AVENUE STREET 2: STE 34 CITY: NEWTON STATE: MA ZIP: 02459 FORMER COMPANY: FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010612 4 1 c23501_4x0.xml MAIN DOCUMENT DESCRIPTION X0304 4 2011-10-19 0001133416 GALECTIN THERAPEUTICS INC GALT.OB 0001412377 Rubin Marc C/O GALECTIN THERAPEUTICS INC. 7 WELLS AVENUE, SUITE 34 NEWTON MA 02459 1 0 0 0 Common stock 2011-10-18 4 P 0 20000 0.96 A 20000 D The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.95 to $0.97 inclusive. The reporting person undertakes to provide Galectin Therapeutics Inc., any security holder of Galectin Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. /s/ Maureen E. Foley, Attorney-in-Fact for Marc Rubin 2011-10-19